The clinical utility of botulinum toxin type A for plantar hyperhidrosis

Ohshima Yuichiro0 个研究点目标入组 40 人开始时间: 2021年9月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients who meet the criteria of primary focal hyperhidrosis for plantar; Focal, visible, excessive sweating of at least 6 months duration without apparent cause with at least two of the following characteristics:
•1) Age of onset less than 25 years
•2) Bilateral and relatively symmetric
•3) Cessation of focal sweating during sleep
•4) Frequency of at least one episode per week
•5) Positive family history
•6) Impairs daily activities

•Patients who has symptom of irritation ag ainst component of botulinum toxin type A.
•Preg nant women or women who may be pregnant.
•Patients with systemic neuromuscular junction dysfunction (myasthenia g ravis, Lambert-Eaton synd
•rome, amyotrophic lateral sclerosis and others).
•Patients who was treated by botulinum toxin type A within 1 year and suspected the presence of neutralizing antibodies.
•Patients who are using other types of botulinum toxin and muscle relaxants (tubocurarine chloride hydrochloride hydrate, dantrolene sodium hydrate and others).
•In case a patient conducts other treatments for hyperhidrosis (external or internal medicine), s/he needs to have a washout period for 1 month.

发起方

Ohshima Yuichiro